セルソースの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/01/17 | 4,700 | 4,760 | 4,395 | 4,425 | -255 | -5.4% | 268,500 |
| 2022/01/14 | 4,670 | 4,750 | 4,555 | 4,680 | -165 | -3.4% | 221,300 |
| 2022/01/13 | 4,970 | 5,160 | 4,820 | 4,845 | -215 | -4.2% | 201,700 |
| 2022/01/12 | 4,955 | 5,200 | 4,935 | 5,060 | +315 | +6.6% | 288,600 |
| 2022/01/11 | 4,645 | 4,765 | 4,530 | 4,745 | +170 | +3.7% | 293,200 |
| 2022/01/07 | 4,710 | 4,710 | 4,440 | 4,575 | -65 | -1.4% | 337,400 |
| 2022/01/06 | 4,600 | 4,920 | 4,550 | 4,640 | -170 | -3.5% | 406,700 |
| 2022/01/05 | 4,970 | 5,060 | 4,775 | 4,810 | -480 | -9.1% | 459,100 |
| 2022/01/04 | 5,600 | 5,620 | 5,150 | 5,290 | -140 | -2.6% | 332,000 |
| 2021/12/30 | 5,410 | 5,470 | 5,270 | 5,430 | -80 | -1.5% | 262,800 |
| 2021/12/29 | 5,600 | 5,730 | 5,430 | 5,510 | -120 | -2.1% | 351,700 |
| 2021/12/28 | 5,620 | 5,700 | 5,080 | 5,630 | +80 | +1.4% | 761,100 |
| 2021/12/27 | 5,250 | 5,640 | 5,170 | 5,550 | +280 | +5.3% | 679,100 |
| 2021/12/24 | 4,970 | 5,450 | 4,925 | 5,270 | +335 | +6.8% | 864,100 |
| 2021/12/23 | 4,670 | 4,970 | 4,575 | 4,935 | +240 | +5.1% | 655,700 |
| 2021/12/22 | 4,445 | 4,735 | 4,375 | 4,695 | +255 | +5.7% | 472,400 |
| 2021/12/21 | 4,560 | 4,575 | 4,245 | 4,440 | +20 | +0.5% | 619,700 |
| 2021/12/20 | 4,750 | 4,850 | 4,420 | 4,420 | -140 | -3.1% | 687,100 |
| 2021/12/17 | 4,950 | 4,975 | 4,460 | 4,560 | -590 | -11.5% | 970,100 |
| 2021/12/16 | 5,390 | 5,430 | 5,030 | 5,150 | +60 | +1.2% | 665,500 |
| 2021/12/15 | 5,290 | 5,430 | 5,020 | 5,090 | -600 | -10.5% | 1,156,500 |
| 2021/12/14 | 6,590 | 6,800 | 5,690 | 5,690 | -1,500 | -20.9% | 888,200 |
| 2021/12/13 | 7,680 | 7,690 | 7,030 | 7,190 | -340 | -4.5% | 438,800 |
| 2021/12/10 | 7,930 | 8,120 | 7,520 | 7,530 | -340 | -4.3% | 424,800 |
| 2021/12/09 | 7,850 | 8,160 | 7,480 | 7,870 | +870 | +12.4% | 985,100 |
| 2021/12/08 | 6,890 | 7,190 | 6,860 | 7,000 | +210 | +3.1% | 199,900 |
| 2021/12/07 | 7,070 | 7,080 | 6,680 | 6,790 | -100 | -1.5% | 186,900 |
| 2021/12/06 | 6,830 | 7,030 | 6,670 | 6,890 | ±0 | ±0% | 171,000 |
| 2021/12/03 | 6,600 | 6,910 | 6,400 | 6,890 | +430 | +6.7% | 199,500 |
| 2021/12/02 | 6,590 | 6,710 | 6,400 | 6,460 | -230 | -3.4% | 120,600 |
| 2021/12/01 | 6,760 | 6,910 | 6,450 | 6,690 | -70 | -1% | 160,400 |
| 2021/11/30 | 7,140 | 7,230 | 6,690 | 6,760 | -80 | -1.2% | 151,400 |
| 2021/11/29 | 6,760 | 7,070 | 6,650 | 6,840 | -20 | -0.3% | 158,800 |
| 2021/11/26 | 7,110 | 7,150 | 6,780 | 6,860 | -250 | -3.5% | 151,700 |
| 2021/11/25 | 7,320 | 7,320 | 7,020 | 7,110 | -70 | -1% | 93,900 |
| 2021/11/24 | 7,370 | 7,450 | 7,050 | 7,180 | -340 | -4.5% | 160,400 |
| 2021/11/22 | 7,570 | 7,670 | 7,420 | 7,520 | -30 | -0.4% | 110,800 |
| 2021/11/19 | 7,750 | 7,890 | 7,380 | 7,550 | +10 | +0.1% | 172,600 |
| 2021/11/18 | 7,630 | 7,780 | 7,460 | 7,540 | -20 | -0.3% | 135,400 |
| 2021/11/17 | 7,700 | 7,890 | 7,450 | 7,560 | -40 | -0.5% | 217,200 |
| 2021/11/16 | 7,230 | 7,740 | 7,160 | 7,600 | +470 | +6.6% | 327,800 |
| 2021/11/15 | 7,060 | 7,220 | 6,930 | 7,130 | +40 | +0.6% | 117,800 |
| 2021/11/12 | 6,940 | 7,110 | 6,850 | 7,090 | +150 | +2.2% | 95,000 |
| 2021/11/11 | 6,980 | 7,220 | 6,900 | 6,940 | -40 | -0.6% | 120,900 |
| 2021/11/10 | 7,070 | 7,070 | 6,810 | 6,980 | -180 | -2.5% | 121,700 |
| 2021/11/09 | 7,270 | 7,390 | 7,100 | 7,160 | -110 | -1.5% | 114,800 |
| 2021/11/08 | 7,330 | 7,470 | 7,150 | 7,270 | +20 | +0.3% | 230,000 |
| 2021/11/05 | 6,740 | 7,310 | 6,740 | 7,250 | +560 | +8.4% | 325,700 |
| 2021/11/04 | 6,740 | 6,900 | 6,590 | 6,690 | +50 | +0.8% | 104,500 |
| 2021/11/02 | 6,580 | 6,690 | 6,520 | 6,640 | +120 | +1.8% | 53,000 |
701～
750
件表示中 / 1240件
類似銘柄と比較する
現在ご覧いただいている「セルソース」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| セルソース | 111,700円 | -3.0% | -55.9% | 0.45% | 53.06倍 | 3.66倍 |
|
脂肪・血液由来の細胞加工受託など再生医療、変形性ひざ関節症向け軸に不妊治療関連も展開 |
| ミズホメディ | 163,000円 | -5.1% | -21.2% | 4.91% | 10.29倍 | 1.96倍 |
|
体外検査薬専業、感染症抗体、遺伝子検査機器、試薬開発。新型コロナで急成長、妊娠検査薬も |
| 扶桑薬 | 266,000円 | +8.3% | +98.1% | 3.08% | 8.74倍 | 0.60倍 |
|
人工腎臓用透析剤・補液が主軸の製薬中堅、透析剤は国内シェア５割。後発薬や製造受託も展開 |
| ステムリム | 35,800円 | - | - | 0.00% | - | 2.91倍 |
|
大阪大学発バイオベンチャー。損傷細胞の活性化物質を動員、再生を促す「再生誘導医薬」を開発 |
| 大幸薬品 | 36,400円 | +11.1% | - | 0.00% | 33.21倍 | 2.26倍 |
|
止瀉薬「正露丸」で有名な大衆薬中堅。オーナー経営色。不振の「クレベリン」など事業再構築中 |
市場注目の銘柄
チャート関連のコラム
